|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009429,
umls-concept:C0010583,
umls-concept:C0030705,
umls-concept:C0059985,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0332293,
umls-concept:C0556895,
umls-concept:C0596611,
umls-concept:C0598666,
umls-concept:C0750502,
umls-concept:C0877857
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-9-6
|
|
pubmed:abstractText |
To study prognostic factors in previously untreated patients receiving FC regimen (fludarabine plus cyclophosphamide).
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0040-3660
|
|
pubmed:author |
pubmed-author:BidermanB VBV,
pubmed-author:Koloshe?novaT ITI,
pubmed-author:KolosovaL IuLIu,
pubmed-author:KovalevaL GLG,
pubmed-author:LorieIu IuIuIu,
pubmed-author:NikitinE AEA,
pubmed-author:RisinskaiaN ANA,
pubmed-author:SalogubG NGN,
pubmed-author:StadnikE AEA,
pubmed-author:SudarikovA BAB,
pubmed-author:TsybaN NNN,
pubmed-author:Zaritski?Iu AIuA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
66-70
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17802794-Adult,
pubmed-meshheading:17802794-Aged,
pubmed-meshheading:17802794-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17802794-Cyclophosphamide,
pubmed-meshheading:17802794-Female,
pubmed-meshheading:17802794-Humans,
pubmed-meshheading:17802794-Immunoglobulin Variable Region,
pubmed-meshheading:17802794-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:17802794-Male,
pubmed-meshheading:17802794-Middle Aged,
pubmed-meshheading:17802794-Mutation,
pubmed-meshheading:17802794-Prognosis,
pubmed-meshheading:17802794-Treatment Outcome,
pubmed-meshheading:17802794-Vidarabine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide].
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
